These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8312423)

  • 1. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD.
    Bunchman TE; Swartz RD
    Perit Dial Int; 1994; 14(1):81-4. PubMed ID: 8312423
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
    Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
    Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1.
    Yamauchi T; Quillard M; Takahashi S; Nguyen-Khoa M
    Nephrol Dial Transplant; 2001 Dec; 16(12):2407-11. PubMed ID: 11733634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
    Illies F; Bonzel KE; Wingen AM; Latta K; Hoyer PF
    Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ; Swee ML; Fillaus JA
    Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long daily hemodialysis sessions correct systemic complications of oxalosis prior to combined liver-kidney transplantation: case report.
    Díaz C; Catalinas FG; de Alvaro F; Torre A; Sánchez C; Costero O
    Ther Apher Dial; 2004 Feb; 8(1):52-5. PubMed ID: 15128020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
    Hoppe B; Dittlich K; Fehrenbach H; Plum G; Beck BB
    Am J Kidney Dis; 2011 Sep; 58(3):453-5. PubMed ID: 21705122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes.
    Marangella M; Vitale C; Petrarulo M; Linari F
    Nephrol Dial Transplant; 1995; 10 Suppl 8():11-3. PubMed ID: 8592617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria.
    Marangella M; Petrarulo M; Cosseddu D; Vitale C; Linari F
    Am J Kidney Dis; 1992 Jun; 19(6):546-53. PubMed ID: 1595703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004.
    Jamieson NV;
    Am J Nephrol; 2005; 25(3):282-9. PubMed ID: 15961948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary hyperoxaluria or oxalosis. Apropos of a case].
    Bayoudh F; Landthaler G; Hue G; Hecketsweiler B; Mallet E
    Ann Pediatr (Paris); 1989 May; 36(5):321-5. PubMed ID: 2742316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystalline retinopathy in primary hyperoxaluria.
    Punjabi OS; Riaz K; Mets MB
    J AAPOS; 2011 Apr; 15(2):214-6. PubMed ID: 21596303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and urine measurements for monitoring of treatment in the primary hyperoxaluric patient.
    Kasidas GP
    Nephrol Dial Transplant; 1995; 10 Suppl 8():8-10. PubMed ID: 8592630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of late-onset primary hyperoxaluria type 1.
    Blaschke S; Grupp C; Haase J; Kleinoeder T; Hallermann C; Troche I; Gröne HJ; Müller GA
    Am J Kidney Dis; 2002 Feb; 39(2):E11. PubMed ID: 11840402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival on renal replacement therapy for primary hyperoxaluria type I.
    Calzavara P; Marangella M; Petrarulo M; Ballanti P; Bonucci E; Calconi G; Maresca MC; da Porto A; Vianello A
    Nephron; 1993; 63(2):217-21. PubMed ID: 8450916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal transplantation in primary hyperoxaluria/oxalosis: a report of two cases.
    Paul MD; Parfrey PS; Harnett JD; Arbus G; Cohen A; Dancey J; Gault MH
    Transplant Proc; 1987 Aug; 19(4):3431-2. PubMed ID: 3303511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.